Banco Santander’s GSK GSK Stock Holding History

Banco Santander’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,752	Closed	-$857K	–	359
2022 Q2	$857K	Buy	+15,752	New	+$870K	0.01%	287
2020 Q2	–	Sell	-9,672	Closed	-$458K	–	384
2020 Q1	$458K	Sell	9,672 -2,936	-23%	-$157K	0.01%	319
2019 Q4	$741K	Sell	12,608 -424	-3%	-$23.6K	0.01%	294
2019 Q3	$698K	Buy	13,032 +3,408	+35%	+$175K	0.01%	288
2019 Q2	$480K	Sell	9,624 -6,320	-40%	-$317K	﹤0.01%	314
2019 Q1	$823K	Sell	15,944 -8,176	-34%	-$409K	0.01%	253
2018 Q4	$1.15M	Sell	24,120 -4,456	-16%	-$219K	0.01%	227
2018 Q3	$1.44M	Sell	28,576 -5,976	-17%	-$304K	0.02%	220
2018 Q2	$1.74M	Sell	34,552 -8,288	-19%	-$417K	0.02%	200
2018 Q1	$2.11M	Buy	+42,840	New	+$2M	0.02%	197

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Banco Santander's GSK Position: Q3 2022 in Review

Banco Santander sold out of GSK (GSK) in Q3 2022, closing a stake of 15,752 shares — an estimated $857K sold.

Banco Santander first reported a position in GSK in Q1 2018 and held it in 10 quarters. The position peaked at $2.11M in Q1 2018. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Banco Santander reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Banco Santander sold 15,752 GSK shares in Q3 2022, an estimated $857K.
Banco Santander first reported a position in GSK in Q1 2018 and held it in 10 quarters.
Banco Santander's GSK position peaked at $2.11M in Q1 2018.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Banco Santander's 13F filing for Q3 2022, filed 8 Nov 2022.